---
title: "药明生物技术有限公司 (WXXWY.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/WXXWY.US.md"
symbol: "WXXWY.US"
name: "药明生物技术有限公司"
industry: "生命科学工具与服务"
---

# 药明生物技术有限公司 (WXXWY.US)

| Item | Detail |
|------|--------|
| Industry | 生命科学工具与服务 |
| Location | 美股市场 |
| Website | [www.wuxibiologics.com](https://www.wuxibiologics.com) |

## Company Profile

无锡生物制药（开曼）有限公司是一家投资控股公司，为中国大陆、北美、欧洲、新加坡、日本、韩国和澳大利亚的生物制药行业提供端到端的生物制药发现、开发和制造解决方案和服务。公司分为两个业务板块：生物制药和 XDC。该公司提供一系列生物制药发现解决方案，从概念到 IND，无缝过渡到 CMC 和下游工艺开发，通过其合同研究、开发和制造组织平台，包括 WuXiBody、SDArBodY、T 细胞结合剂、单 B 细胞克隆技术、WuXia、WuXiUP、WuXiUI 和 WuXiHigh。此外，公司还提供与生物制药技术相关的咨询服务、国际销售合同服务、测试和测试技术开发、销售和营销服务、医疗产品生产和销售，以...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-17T04:30:12.000Z

**Overall: B (0.33)**

**Industry**: Life Sciences Tools and Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 4 / 62 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 17.76% |  |
| Net Profit YoY | 60.23% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 3.48 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 21.83B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 2.79B |  |


**Multi Score**: B

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 9.80% | B |
| Profit Margin | 20.92% | A |
| Gross Margin | 42.73% | B |

#### Growth Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 17.76% | B |
| Net Profit YoY | 60.23% | B |
| Total Assets YoY | 9.15% | B |
| Net Assets YoY | 11.37% | B |

#### Cash Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 477.91% | C |
| OCF YoY | 17.76% | B |

#### Operating Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.34 | D |

#### Debt Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 18.82% | A |


```chart-data:radar
{
  "title": "Longbridge Financial Score - 药明生物技术有限公司",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "9.80%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "20.92%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "42.73%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "B",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "17.76%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "60.23%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "9.15%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "11.37%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "B",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "477.91%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "17.76%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "D",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.34",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "A",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "18.82%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | ChromaDex (US.CDXC) | A | A | A | B | B | A |
| 02 | 安捷伦科技 (US.A) | A | C | B | C | C | B |
| 03 | 沃特世 (US.WAT) | A | B | B | C | C | B |
| 04 | 药明生物(ADR) (US.WXXWY) | B | B | D | A | B | B |
| 05 | 西氏医药服务 (US.WST) | B | B | B | B | C | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 37.37 | 15/59 | 34.71 | 30.75 | 27.71 |
| PB | 3.48 | 36/59 | 3.05 | 2.68 | 2.20 |
| PS (TTM) | 7.82 | 46/59 | 6.85 | 6.02 | 5.00 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/WXXWY.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/WXXWY.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/WXXWY.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.